search
for
 About Bioline  All Journals  Testimonials  Membership  News


Indian Journal of Cancer
Medknow Publications on behalf of Indian Cancer Society
ISSN: 0019-509X EISSN: 1998-4774
Vol. 46, Num. 3, 2009, pp. 246-247

Indian Journal of Cancer, Vol. 46, No. 3, July-September, 2009, pp. 246-247

Letter To Editor

Enterocolic fistula associated with a gastrointestinal stromal tumor

Department of Surgery, Hormozgan University of Medical Sciences, Bandarabbas
Correspondence Address:Department of Surgery, Hormozgan University of Medical Sciences, Bandarabbas
psrg.sums@yahoo.com

Code Number: cn09056

PMID: 19574683
DOI: 10.4103/0019-509X.52965

Sir

Gastrointestinal stromal tumors (GIST) are the most common primary mesenchymal tumors of the gastrointestinal (GI) tract. [1] GIST usually displace the adjacent organ and have rarely been reported with intraperitoneal rupture or organ invasion. [2],[3] The following case describes a 70-year-old male patient with anemia and chronic diarrhea, who underwent colonoscopic examination. The findings on colonoscopy revealed a large, enterocolic fistula at the spelnic flexure of the colon. Physical examination and Laboratory studies were unremarkable except for the presence of a vague lump in the left upper quadrant and hemoglobin of 7.8 g/dL, respectively. Ultrasonography and computed tomography (CT) showed a mass (8 x 8 cm) at the splenic flexure and a metastatic lesion in the liver. [Figure - 1] and [Figure - 2] Exploration revealed a large diverticulum, which contained a mass that originated from the proximal jejunum and adhered to the medial border of spelenic flexure, associated with entrocolic fistula. Large intraperitoneal and liver metastases were also found. The bowel walls along with the fistula tract were resected and repaired, but the patient was not physiologically suitable for resection of the metastatic lesions. The patient did well in the postoperative period on Imatinib (400 mg/day) during the six-month follow-up. Pathology showed a spindle stromal tumor with low mitosis that was positive for CD117 (Gist tumor). [Figure - 3]

Enterocolic fistulas are usually caused by inflammatory conditions such as inflammatory bowel disease. This abnormal communication can also be caused by prior surgery, foreign bodies, pancreatitis, diverticulitis, and, most ominously, by malignancy. [4]

The most common sites of tumors are the stomach and small intestine. Most patients with GIST (70%) have symptoms, however, 10% of them are only detected at autopsy. The most common symptom of GIST is anemia due to bleeding from mucosal ulceration. [1],[5],[6]

According to our knowledge this presentation of the GIST tumor has been the first report, not only considering the site of occurrence, but also the aggressiveness of the tumor that caused the entrocolic fistula. However, fistula formation can also be explained by tumor pressure and intraperitoneal rupture of the diverticula in advanced GIST, although, in this case the patient had never developed any signs of tumor rupture in his past medical history.

Surgery is the definitive therapy for patients with GIST tumor, as radiotherapy and chemotherapy have not been found to be effective in its treatment . Imatinib a selective and competitive inhibitor of tyrosine kinase, has been found to a of metastatic and locally advanced GISTs. We did not resect the metastatic lesions and the patient received only Imatinib, with good response in follow-up. [6]

References

1.Miettinen M, Lasota J. Gastrointestinal stromal tumors: Pathology andprognosis at different sites. Semin Diagn Pathol 2006;23:70-83.  Back to cited text no. 1  [PUBMED]  
2.Van der Zwan SM, De Matteo RP. Gastrointestinal stromaltumour: 5 years later. Cancer 2005;104:1781-8.  Back to cited text no. 2    
3.Judson I. Gastrointestinal stromal tumour (GIST): Biology andtreatment. Ann Oncol 2002;13:287-9.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Kumar A, West JC, Still, C, Komar MJ, Babameto GP. Jejunocolic fistula: An unreported complication of acquired immunodeficiency syndrome-associated lymphoma. J Clin Gastroenterol 2002;34:194-5.  Back to cited text no. 4    
5.Gold JS, De Matteo RP. Combined surgical and moleculartherapy: The gastrointestinal stromal tumor model. Ann Surg 2006;244:176-84.   Back to cited text no. 5    
6.D'Amato G, Steinert DM, Mc Auliffe JC, Trent JC. Update on biology and therapy of gastrointestinal stromal tumours. Cancer Control 2005;12:44-56.  Back to cited text no. 6    

Copyright 2009 - Indian Journal of Cancer


The following images related to this document are available:

Photo images

[cn09056f1.jpg] [cn09056f2.jpg] [cn09056f3.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil